Pharmaceutical Business Review |
UPDATE 1-Actavis, Adamas win FDA approval for Alzheimer's drug
Reuters (Adds details, background, share). Dec 24 (Reuters) – The U.S. Food and Drug Administration approved a drug to treat dementia in Alzheimer's patients that was developed by Actavis Plc and Adamas Pharmaceuticals Inc. Adamas shares were up nearly 17 … Actavis, Adamas Pharma Win FDA Approval For Alzheimer's Drug Namzaric Actavis Alzheimers Drug Approved; Bystolic Gets CRL Actavis, Adamas win FDA approval for Alzheimer's drug |
